These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 38980346

  • 1. Comparative effects of different treatments based on the levonorgestrel intrauterine system in endometrial carcinoma and endometrial hyperplasia patients: a network meta-analysis.
    Tao M, Wu T, Zhou X, Du X, Ling K, Liang Z.
    Arch Gynecol Obstet; 2024 Sep; 310(3):1315-1329. PubMed ID: 38980346
    [Abstract] [Full Text] [Related]

  • 2. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
    Mittermeier T, Farrant C, Wise MR.
    Cochrane Database Syst Rev; 2020 Sep 06; 9(9):CD012658. PubMed ID: 32909630
    [Abstract] [Full Text] [Related]

  • 3. Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials.
    Abu Hashim H, Ghayaty E, El Rakhawy M.
    Am J Obstet Gynecol; 2015 Oct 06; 213(4):469-78. PubMed ID: 25797236
    [Abstract] [Full Text] [Related]

  • 4. Oral and intrauterine progestogens for atypical endometrial hyperplasia.
    Luo L, Luo B, Zheng Y, Zhang H, Li J, Sidell N.
    Cochrane Database Syst Rev; 2018 Dec 04; 12(12):CD009458. PubMed ID: 30521671
    [Abstract] [Full Text] [Related]

  • 5. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Dominick S, Hickey M, Chin J, Su HI.
    Cochrane Database Syst Rev; 2015 Dec 09; 2015(12):CD007245. PubMed ID: 26649916
    [Abstract] [Full Text] [Related]

  • 6. Oral Progestogens Versus Levonorgestrel-Releasing Intrauterine System for Treatment of Endometrial Intraepithelial Neoplasia<sup/>.
    Marnach ML, Butler KA, Henry MR, Hutz CE, Langstraat CL, Lohse CM, Casey PM.
    J Womens Health (Larchmt); 2017 Apr 09; 26(4):368-373. PubMed ID: 27901412
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System: A Korean Gynecologic-Oncology Group Study.
    Kim MK, Seong SJ, Kim JW, Jeon S, Choi HS, Lee IH, Lee JH, Ju W, Song ES, Park H, Ryu HS, Lee C, Kang SB.
    Int J Gynecol Cancer; 2016 May 09; 26(4):711-5. PubMed ID: 26905333
    [Abstract] [Full Text] [Related]

  • 10. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Romero SA, Young K, Hickey M, Su HI.
    Cochrane Database Syst Rev; 2020 Dec 21; 12(12):CD007245. PubMed ID: 33348436
    [Abstract] [Full Text] [Related]

  • 11. Levonorgestrel-releasing intrauterine system versus systemic progestins in management of endometrial hyperplasia: A systemic review and meta-analysis.
    Elassall GM, Sayed EG, Abdallah NA, El-Zohiry MM, Radwan AA, AlMahdy AM, Sedik AS, Elazeem HASA, Shazly SA.
    J Gynecol Obstet Hum Reprod; 2022 Oct 21; 51(8):102432. PubMed ID: 35760334
    [Abstract] [Full Text] [Related]

  • 12. Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer.
    Novikova OV, Nosov VB, Panov VA, Novikova EG, Krasnopolskaya KV, Andreeva YY, Shevchuk AS.
    Gynecol Oncol; 2021 Apr 21; 161(1):152-159. PubMed ID: 33461741
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia.
    Bian J, Shao H, Liu H, Li H, Fang L, Xing C, Wang L, Tao M.
    Reprod Sci; 2015 Jun 21; 22(6):758-66. PubMed ID: 25536958
    [Abstract] [Full Text] [Related]

  • 14. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
    Varma R, Soneja H, Bhatia K, Ganesan R, Rollason T, Clark TJ, Gupta JK.
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug 21; 139(2):169-75. PubMed ID: 18440693
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia.
    Lv X, Guo L, Wang C.
    J Gynecol Oncol; 2024 May 21; 35(3):e27. PubMed ID: 38216133
    [Abstract] [Full Text] [Related]

  • 16. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Chin J, Konje JC, Hickey M.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD007245. PubMed ID: 19821400
    [Abstract] [Full Text] [Related]

  • 17. Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up.
    Gallos ID, Krishan P, Shehmar M, Ganesan R, Gupta JK.
    Hum Reprod; 2013 May 07; 28(5):1231-6. PubMed ID: 23466671
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.